CytomX Therapeutics KZ Index (Annual) Analysis

CytomX Therapeutics, Inc. (CTMX)

5.44 -0.14 (-2.51%) USD | NASDAQ | Feb 24, 16:00

5.51 +0.07 (+1.29%) Pre-Market: 08:54

KZ Index (Annual) Chart

View KZ Index (Annual) for CTMX.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View KZ Index (Annual) Chart

Start Trial

Historical Data

View Historical Data

Start Trial

KZ Index Definition

View KZ Index Definition

Start Trial

The KZ-Index (Kaplan-Zingales Index) is a relative measurement of reliance on external financing. Companies with a higher KZ-Index scores are more likely to experience difficulties when financial conditions tighten since they may have difficulty financing their ongoing operations.

Read full definition.

KZ Index (Annual) Range, Past 5 Years

View KZ Index (Annual) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

KZ Index (Annual) Benchmarks

View KZ Index (Annual) Benchmarks

Start Trial

REGENXBIO, Inc.	--
ACADIA Pharmaceuticals, Inc.	Upgrade
Alnylam Pharmaceuticals, Inc.	Upgrade
Savara, Inc.	--
BioMarin Pharmaceutical, Inc.	Upgrade